Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression
- PMID: 3201248
- DOI: 10.1126/science.3201248
Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression
Abstract
Fibroblasts were genetically modified to secrete nerve growth factor (NGF) by infection with a retroviral vector and then implanted into the brains of rats that had surgical lesions of the fimbria-fornix. The grafted cells survived and produced sufficient NGF to prevent the degeneration of cholinergic neurons that would die without treatment. In addition, the protected cholinergic cells sprouted axons that projected in the direction of the cellular source of NGF. These results indicate that a combination of gene transfer and intracerebral grafting may provide an effective treatment for some disorders of the central nervous system.
Similar articles
-
Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF.J Neurosci Res. 1990 Mar;25(3):405-11. doi: 10.1002/jnr.490250318. J Neurosci Res. 1990. PMID: 2325166
-
Gene therapy in the CNS: intracerebral grafting of genetically modified cells.Prog Brain Res. 1990;86:205-17. doi: 10.1016/s0079-6123(08)63178-7. Prog Brain Res. 1990. PMID: 2087558
-
CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: complete rescue of axotomized cholinergic neurons after transplantation into the septum.J Neurosci. 1995 Aug;15(8):5668-80. doi: 10.1523/JNEUROSCI.15-08-05668.1995. J Neurosci. 1995. PMID: 7643209 Free PMC article.
-
Grafting genetically modified cells to the brain: conceptual and technical issues.Prog Brain Res. 1990;82:1-10. doi: 10.1016/s0079-6123(08)62584-4. Prog Brain Res. 1990. PMID: 1981271 Review. No abstract available.
-
Engineering cells to secrete growth factors.J Neurol. 1994 Dec;242(1 Suppl 1):S5-7. doi: 10.1007/BF00939231. J Neurol. 1994. PMID: 7699410 Review.
Cited by
-
Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals.Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2639-43. doi: 10.1073/pnas.89.7.2639. Proc Natl Acad Sci U S A. 1992. PMID: 1557368 Free PMC article.
-
Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia.Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1636-40. doi: 10.1073/pnas.89.5.1636. Proc Natl Acad Sci U S A. 1992. PMID: 1311846 Free PMC article.
-
Neurotrophic factors in neurodegeneration.Brain Pathol. 2006 Oct;16(4):295-303. doi: 10.1111/j.1750-3639.2006.00036.x. Brain Pathol. 2006. PMID: 17107599 Free PMC article. Review.
-
Genetic therapy for the nervous system.Hum Mol Genet. 2011 Apr 15;20(R1):R28-41. doi: 10.1093/hmg/ddr110. Epub 2011 Mar 23. Hum Mol Genet. 2011. PMID: 21429918 Free PMC article. Review.
-
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.JAMA Neurol. 2018 Jul 1;75(7):834-841. doi: 10.1001/jamaneurol.2018.0233. JAMA Neurol. 2018. PMID: 29582053 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources